FDA approves Tecelra, a gene therapy to treat adults with unresectable or metastatic synovial sarcoma. Tecelra is also the first FDA-approved T cell receptor (TCR) gene therapy.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/KaLZtlR
No comments:
Post a Comment